Regeneron Pharmaceuticals Return On Asset Trend

REGN -- USA Stock  

USD 281.62  4.27  1.49%

This module enables investors to look at Regeneron Pharmaceuticals various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Direct Expenses of 311.7 M, Consolidated Income of 476.6 M or Cost of Revenue of 175.6 M, but also many exotic indicators such as Interest Coverage of 77.0381, Long Term Debt to Equity of 0.196 or Calculated Tax Rate of 10.7856. This module is a perfect complement to use when analyzing Regeneron Pharmaceuticals Valuation or Volatility. It can also complement various Regeneron Pharmaceuticals Technical models. Additionally take a look at analysis of Regeneron Pharmaceuticals Correlation with competitors.

Regeneron Pharmaceuticals Return On Asset Marginal Breakdown

Showing smoothed Return on Average Assets of Regeneron Pharmaceuticals with missing and latest data points interpolated. Return on assets measures how profitable a company is [NetIncCmn] relative to its total assets [AssetsAvg].


          10 Years Trend
 Return on Average Assets 

Regeneron Pharmaceuticals Regression Statistics

Arithmetic Mean 7.42
Geometric Mean 10.14
Coefficient Of Variation 240.85
Mean Deviation 14.33
Median 13.42
Standard Deviation 17.86
Sample Variance 318.94
Range 62.46
R Value 0.47
Mean Square Error 274.88
R Squared 0.22
Significance 0.13
Slope 2.30
Total Sum of Squares 3,508

Regeneron Pharmaceuticals Return On Asset Over Time

2017  15.23 
2018  23.85 
2019  0.12 

Other Fundumenentals of Regeneron Pharmaceuticals